Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis

NCT00125333 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
75
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Anesiva, Inc.